|
Market Cap (24-Jun) $57,456,724 (1,515th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 402,075 |
Shortsold (10-Feb) 29,568 (0.00%) (623rd) |
|
52w High $0.017 |
52w Low $0.003 |
P/E 4.78 |
EPS 0 |
AVE released this announcement to the ASX on 23 May 2023, 12:53. The announcement is not marked as price sensitive, and is 21 page(s) in length and 1.53MB in size.
You can view all announcements from AVE and see how they appear on a price chart on the announcements page.
At the date of this announcement, AVE was 0.001% short sold according to ASIC data. It was ranked the 623rd most shorted stock on the ASX. It remains ranked 623rd as of the latest reported data (10 February 2025).
| Other Recent Announcements from AVE | |
|---|---|
| Update - Application for quotation of securities - AVE | 28 June 2023, 11:48 |
| Application for quotation of securities - AVE | 28 June 2023, 11:43 |
| AVE CBD capsule passes two-year stability milestone | 22 June 2023, 8:57 |
| Chair's Address and CEO Presentation | 23 May 2023, 12:53 |
| Avecho licenses TPM for use in cancer drugs | 22 May 2023, 9:39 |
| Withdrawal of AGM Resolutions 5(c) and 5(d) | 18 May 2023, 8:53 |
| AVE commences manufacturing for Phase III trial | 17 May 2023, 9:22 |
You must be logged in to post a reply.
Avecho Biotechnology 